The evolution of resistant bacteria

The evolution of resistant bacteria
A European study investigated the mechanisms by which antibiotic-resistant bacteria evolve. The genetic determinants of this process could have important implications for the spread of microbial resistance.
Bacterial resistance to antibiotics is a major hurdle for fighting many 
infections. Numerous research efforts try to address the problem by 
identifying novel targets and synthesising new compounds with 
antimicrobial function.
Equally important, however, is understanding the evolutionary and 
genetic factors that drive the emergence and spread of resistant 
pathogens. In this context, the EU-funded 'Specificity of antibiotic 
resistance evolution' (SPECRESEVO) project set out to elucidate how 
resistance is affected during evolution and in different environments.
Partners isolated resistant bacteria experimentally using 
conventional protocols and subjected them to different growth 
conditions. Additionally, they isolated bacteria with a different 
history of antibiotic exposure to find that the effect of mutations 
associated with resistance is largely dependent on the environment and 
the genetic background. Therefore, we need to understand these 
mechanisms first before we can predict bacterial spread and minimise 
antibiotic resistance.
Furthermore, partners studied how resistant bacteria grow in the 
absence of antibiotic pressure. Resistant bacteria continued to have an 
increased fitness, compared to normal species, without reverting to drug
 sensitivity, clearly underscoring the necessity of genetic studies to 
identify the implicated loci.  This competitive fitness was 
mutation-specific and also depended on the genetic background of the 
pathogen.
SPECRESEVO work proved the principle that experimental microbial 
evolution is a valid approach for determining key aspects related to 
antibiotic resistance. Collectively, the generated information sheds 
light onto the complex process of resistance-mediated fitness and 
suggests avenues to prohibit resistant bacterial spread. Long-term, this
 is expected to improve health care and minimise related costs.
published: 2015-02-11